Search This Blog

Friday, February 22, 2019

Intercept initiated with an Underperform at SVB Leerink

SVP Leerink analyst Pasha Sarraf initiated Intercept Pharmaceuticals with an Underperform rating and $70 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)